Johnathan Joffe

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

Andrew Webb, David Cunningham, J.H. Scarffe et al. · Journal of Clinical Oncology · 1997 · 873 citations

Medicine, Oncology, Pharmacology +15

Randomized Trial of Carboplatin Versus Radiotherapy for Stage I Seminoma: Mature Results on Relapse and Contralateral Testis Cancer Rates in MRC TE19/EORTC 30982 Study (ISRCTN27163214)

R. Timothy D. Oliver, Graham M. Mead, Gordon Rustin et al. · Journal of Clinical Oncology · 2011 · 314 citations

Medicine, Oncology, Radiation Oncology +16

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

Justin S. Waters, A. Norman, David Cunningham et al. · British Journal of Cancer · 1999 · 278 citations · Full text

Medicine, Oncology, Pharmacology +15

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

S. Krege, Rainer Souchon, Peter Albers et al. · European Urology · 2008 · 252 citations

Medicine, Cancer Biology, Oncology +17

Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial

Robert H. Jones, Angela Casbard, Margherita Carucci et al. · The Lancet Oncology · 2020 · 227 citations · Full text

Medicine, Oncology, Pharmacology +17